Anthony Mouchantaf

Sep 28, 2026

Biossil hits $1B valuation after OpenAI-led $153M round to revive failed drugs

Biossil raises $153M led by OpenAI to resurrect abandoned drug candidates using AI, hitting $1B valuation.